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Signal normalizationAbstract The rapid growth of single-cell RNA-seq studies (scRNA-seq) demands efﬁcient data
storage, processing, and analysis. Big-data technology provides a framework that facilitates the
comprehensive discovery of biological signals from inter-institutional scRNA-seq datasets. The
strategies to solve the stochastic and heterogeneous single-cell transcriptome signal are discussed
in this article. After extensively reviewing the available big-data applications of next-generation
sequencing (NGS)-based studies, we propose a workﬂow that accounts for the unique characteris-
tics of scRNA-seq data and primary objectives of single-cell studies.Introduction
Multi-institutional collaborative omics studies on the next-
generation sequencing (NGS) platform have generated peta-
bytes of data that constitute ‘big data’ from the perspective
of scale and complexity [1–6]. Particularly, transcriptomics
studies using the RNA-seq technique have become revolution-
ary and powerful [7–9]. Scientists have now moved one step
forward to single-cell RNA sequencing (scRNA-seq) by
employing new protocols for single cell isolation, low-input
RNA extraction, reverse transcription, and unbiased ampliﬁ-
cation [9–13]. Given the high anticipated value of single-cell
transcriptomics, explosive growth of scRNA-seq data is
expected in the next 5–10 years. Consequently, uncoveringthe hidden pattern, connectivity, and interactions of such huge
and heterogeneous data will be a major challenge.
Without a doubt, the detailed and extremely-valuable infor-
mation that single-cell technology provides is at a signiﬁcant
cost due to sophisticated data acquisition, large data-storage
requirements, as well as challenging data processing and man-
agement. Big data incorporate a body of technologies includ-
ing computational parallelization and distribution, data
visualization, and data integration that are used to reveal the
hidden associations within large datasets that are diverse, com-
plex, and of a massive scale. Data-intensive scientiﬁc discovery
has been proposed as the 4th paradigm of scientiﬁc research
[14], following and interacting with the other three paradigms
– theory, experimentation, and simulation modeling. In 2001,
Doug Laney deﬁned characteristics of big data in three dimen-
sions, i.e., increasing volume (amount of data), velocity (speed
of data I/O), and variety (range of data types and sources) [15].
While agreeing that volume, variety, and velocity are the quan-
titative characteristics of big data, Ivanov et al. [16] added that
variability (the inconsistency the data can show over time) and
veracity (the quality of captured data) are the qualitative char-
acteristics of big data.nces and
22 Genomics Proteomics Bioinformatics 14 (2016) 21–30Big-data technology has many applications in biomedical
research [17–20]. Particularly, high-throughput molecular
and functional proﬁling of patients using NGS or single-cell
technology is the key driving force of precision medicine
[21–24]. By examining the annual growth of scRNA-seq data-
sets uploaded to the NCBI Gene Expression Omnibus (GEO)
database [25] and the increasing number of new articles in
PubMed over the past 7 years that involve scRNA-seq and
big-data (Figure 1), we expect the extensive integration of big
data and scRNA-seq technologies.
In the following sections, we will discuss the characteristics
of single-cell transcriptomics, especially scRNA-seq, data as
examples of big data. We will discuss how to adapt single-
cell transcriptomics study to big-data infrastructure such as
Hadoop and MapReduce.
Transcriptional stochasticity and cellular
heterogeneity
scRNA-seq is always compared to bulk RNA-seq in terms of
signal proﬁle and noise level. In addition to the descriptive key-
word like high resolution, stochasticity and heterogeneity are
also frequently used to feature the single-cell transcription
[26–29]. Most of the scRNA-seq investigators have experience
with zero-inﬂation transcriptional signals. Some of them tend
to regard this phenomenon as technical dropout. We prefer
to use the phrase ‘‘bimodality” to delineate the signal distribu-
tion, since recent results have shown that the low transcrip-
tional values are biologically meaningful signals rather than
technical dropout. Shalek et al. have revealed the bimodalityFigure 1 Number of papers/datasets addressing single-cell data
and big data
Searches were performed on January 04, 2016 on http://www.ncbi.
nlm.nih.gov/gds for datasets and http://www.ncbi.nlm.nih.gov/
pubmed for papers. Data were obtained according to the search
criteria as follows ﬁltered by year: (1) for scRNA-seq datasets on
GEO: ‘‘single cell”[All Fields] AND ‘‘Expression proﬁling by high
throughput sequencing”[Filter]; (2) for scRNA-seq papers on
PubMed: ‘‘single cell”[All Fields] AND (‘‘rna-seq”[All Fields] OR
‘‘rna sequencing”[All Fields] OR (‘‘sequencing”[All Fields] AND
‘‘transcriptome”[All Fields])); and (3) for big-data papers on
PubMed: ‘‘big data”[All Fields] OR ‘‘hadoop”[All Fields].of single-cell expression and splicing using both scRNA-seq
and RNA ﬂuorescence in situ hybridization (RNA-FISH)
[30]. The two modes in an expression proﬁle can be attributed
to the ‘‘on” or ‘‘off” transcriptional status. Figure 2 demon-
strates two clusters of cells showing different expression level
and the change of the ratio of on/off status of a marker gene
MYH2 over time during human myoblast cell differentiation
using both scRNA-seq and RNA-FISH [31]. The
aforementioned studies indicate that even from a seemingly
homogeneous population, many genes are expressed in a
stochastically-bursting fashion and their abundance exhibits
a bimodal distribution in the cell population examined. The
traditional RNA-seq analysis method rarely takes such tran-
scriptional bimodality into account. Further investigation on
co-bursting networks have validated the biological signiﬁcance
of the ‘‘bimodality” rather than just relegating it to technical
dropout [31].
Several computational models have been proposed to ana-
lyze transcriptional stochasticity and cellular heterogeneity in
scRNA-seq data in the context of zero-inﬂation or bimodality.
Kim and Marioni [32] use a mixture of two Poisson distribu-
tions to model theoretical kinetics for ‘bursty’ gene expression.
However, in the presence of massive variability, the model is
compromised by excessive over-dispersion in read counts.
Kharchenko et al. take the probability of ‘‘dropout” into con-
sideration in their differential-expression algorithm [33]. Pier-
son and Yau proposed using zero-inﬂated factor analysis to
perform dimensionality reduction [29]. Gu et al. use a mixture
of two negative binomial distributions to model over-dispersed
read counts generated from a gene’s two distinct biological
states: an ‘on’ component and an ‘off’ component [31]. All
of these four studies acknowledge the fact that single-cell tran-
scription signals cannot be solved by unimodal statistics. Gu
et al. ﬁrst introduced the statistics term ‘‘bimodal proportion”
to measure the ratio of two signal modes in a single-cell pop-
ulation. The functional enrichment of co-bursting transcrip-
tion supports the biological signiﬁcance of transcriptional
bursting over technical dropout. The value of ‘‘bimodal pro-
portion” ranges from 0 to 1 and notably, it can be compared
across different datasets without additional normalization.The opportunities and challenges of scRNA-seq
Single-cell transcriptomics provides us unprecedented oppor-
tunity to understand the transcriptional stochasticity and cellu-
lar heterogeneity in great detail, which are crucial for
maintaining cell functions and for facilitating disease progres-
sion or treatment response [34–38]. Such stochasticity and
heterogeneity are always masked in bulk-cell studies [27].
Recent single-cell applications have utilized a broad range of
tissues [28,39–42], stem cell lines [43,44] and cell populations
with clinical backgrounds [45]. The cell types that have been
interrogated using scRNA-seq in the GEO database are brieﬂy
summarized in Table 1.
scRNA-seq is one of the most promising technologies for
single-cell transcriptomics [46,47]. Nevertheless, it also poses
big challenges, largely stemming from the aforementioned
big-data characteristics with regard to the data management,
query, and analysis. There are ﬁve ‘V’s to consider for
scRNA-seq data. (1) Volume. NGS data has become one of
the largest big-data domains in terms of data acquisition,
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Figure 2 MYH2 gene is the marker of mature myotubes
The increased bulk expression ofMYH2 is primarily driven by the growing proportion of ‘‘on-” component cells (upper cluster) over time
(0, 24, 48, and 72 h after myoblast differentiation is induced). Figures were derived from the dataset in Trapnell et al [41]. A. The growth of
MYH2 expression in bulk cell replicate samples (n= 3 over time). B. Beeswarm plots of the growing bimodal proportion of MYH2 from
scRNA-seq over time. C–F. RNA-FISH signals at 0, 24, 48, and 72 h, respectively. MYH2 and nucleus are shown in red and blue (DAPI
staining), respectively. Scare bar: 25 nm. G.MYH2 RNA molecule counts per cell over time, based on RNA-FISH analyses. RNA-FISH,
RNA-ﬂuorescence in situ hybridization.
Table 1 Summary of cell types in GEO datasets
Cell type No. of datasets
Neuron 11
Embryonic 80
Blood 18
Lung 17
Renal 4
Brain 17
Skin 26
Heart 9
Bone marrow 17
Stem cell 43
Tumor 23
Cell line 71
Total No. of unique datasets 195
Yu P and Lin W / scRNA-seq and Big Data 23storage, and distribution [48]. Just like bulk-cell RNA-seq and
other NGS-based studies, scRNA-seq generates a high volume
of raw sequencing data and high-dimensional transformed
expression data. Moreover, due to the heterogeneity of cell
populations, a typical scRNA-seq study usually incorporates
hundreds or even thousands of cells and thus adds a few more
orders of magnitude to the data volume. (2) Velocity. As afore-
mentioned, the data volume of scRNA-seq is higher than thatof bulk-cell RNA-seq. Consequently, high data-transfer band-
width, parallel algorithms, and high-performance computers
are required to generate and process data. (3) Variety. An
scRNA-seq study may combine data from different single-
cell isolation chips, protocols, and research environments.
How to normalize the datasets and make them comparable
becomes a major issue. (4) Variability. The transcriptional
activity of a living cell is dynamic rather than static. Thus,
scRNA-seq captures a snapshot of single cells in seemingly
homogeneous populations that as a matter of fact, vary signif-
icantly from one to another. Substantial variability of the
scRNA-seq signal comes from a variety of biological aspects,
including transcriptional stochasticity and cellular heterogene-
ity, which cannot be investigated in bulk-cell studies. There-
fore, scRNA-seq data exhibit signiﬁcantly larger variance
than bulk-cell RNA-seq data [33]. Solving the biological vari-
ability is the main goal of single-cell transcriptomics research.
(5) Veracity. scRNA-seq is composed of sequential steps of
target cell isolation, RNA extraction, fragmentation, reverse
transcription, cDNA ampliﬁcation, sequencing, alignment,
and read counting. Every step introduces biases and artifacts
that may signiﬁcantly affect the coverage, accuracy, and time-
liness of transcript expression and thus interfere with both the
proper characterization and quantiﬁcation of transcripts. It is
therefore critical to control the data quality prior to including
the datasets in a meaningful global study.
24 Genomics Proteomics Bioinformatics 14 (2016) 21–30Due to the much lower starting amount of RNA in a single
cell, it takes more cycles of ampliﬁcation using a template-
switching strategy, compared to the bulk-cell sequencing
[49,50] and thus introduces much larger technical variations
to the scRNA-seq data. Technical variations in scRNA-seq
include but not limit to the ones introduced by RNA extrac-
tion, transcript fragmentation, reverse transcription, PCR
ampliﬁcation, sequencing sampling, sequencing error, short-
read mapping error, and miscount. Because the technical vari-
ation introduced during earlier steps will be carried over to the
later steps and even be ampliﬁed further, it is critical to control
the technical variations in the earlier steps. Artiﬁcial RNA
molecules such as the External RNA Controls Consortium
spike-in molecules (ERCC) can be doped into the assayed
RNA samples at the same level. Since there is no expected bio-
logical variation for the ERCC transcripts in the samples, the
variation in the ERCC quantiﬁcation measurements in the
scRNA-seq will be due to technical variability. This is a reli-
able way to quantify technical variation in scRNA-seq [51].
Technical variations may confound with biological variations,
and we can only observe total variation in gene expression.
Efforts have been made to distinguish the technical variation
from biological variation in scRNA-seq by computational
methods with or without ERCC control [52,53].
The best efforts at mitigating the technical variations have
been made by protocol modiﬁcation. Saliba et al. [10] and
Kolodziejczyk et al. [54] have reviewed a variety of single-cell
RNA-seq techniques. Besides including external molecule con-
trols, improved single-cell chemistry and physics [8,9,55], as
well as incorporation of molecular barcoding system [56], have
signiﬁcantly reduced the noise level within each study.Big data—the norm of NGS technology
A typical RNA-seq study on the most popular NGS platform
such as the Illumina HiSeq 2500 usually generates hundreds of
gigabytes (GB) of raw read data. It usually takes hours to align
these raw reads to the human or other mammalian reference
genomes. The NGS throughput and computer processors are
in a race and the growth of NGS data always seems to win
[57]. Moreover, a robust data storage, management and anal-
ysis framework is in need.
The National Center for Biotechnology Information
(NCBI) hosts RNA-seq data using two data storage/sharing
platforms, i.e., Gene Expression Omnibus database (GEO)
[25,58] and Sequence Read Archive database (SRA) [59]. Both
of these databases provide comprehensive metadata structure,
including information about the data producer, study design,
sample description, technical details, keywords, etc. The meta-
data that they collect has been considered as data-sharing stan-
dards and the overall bioinformatics infrastructure in a big-
data system.
Apache Hadoop is an open-source software framework for
distributed storage and distributed processing of very large
datasets on computer clusters. The key modules in the Apache
Hadoop framework are the Hadoop Distributed File System
(HDFS) and Hadoop MapReduce. Apache Hadoop uses its
HDFS to store data on commodity machines, providing very
high aggregate bandwidth across the cluster. In addition,
Apache Hadoop implements MapReduce technology [60] to
decompose a large-scale problem into small independentsub-problems and schedule the sub-problems to computer
clusters. MapReduce allows the development of approaches
that can handle larger volumes of data using a larger number
of processors simultaneously. By utilizing parallel-based
approaches, Apache Hadoop improves the ﬂexibility and scal-
ability of computer clusters.
scRNA-seq utilizes the most common short-read mapping,
as well as data storage and query procedures of common NGS
applications. The Hadoop-based bioinformatics applications
[61–91] are reviewed in Table 2. To our best knowledge, there
is no Hadoop application specially designed for scRNA-seq so
far. Given the unique bimodal signal proﬁle of scRNA-seq
data, the long-used unimodal statistics in bulk RNA-seq can-
not satisfy the need to determine differential expression in
scRNA-seq. It has also been validated that change of bimodal
proportion/burst frequency as well as the coordination of tran-
scriptional bursts are biologically meaningful [31]. Thus the
new analytic components should be included when mining
the scRNA-seq data in the big-data domain.
A robust normalization underlies the success of analyses
across datasets. The goal of using a big-data approach for
scRNA-seq studies is not just to take full advantage of the
computational resources on the cloud but also to integrate
the sample power of multiple single-cell datasets to uncover
the global associations and the molecular mechanisms that
maintain the cellular function of biological systems. Reference
like ERCC for signal normalization, as discussed above, can be
added on the bench side. On the computational side, signal-
rescaling algorithms (Table 3) based on the putative abun-
dance of internal references (e.g., ERCC and housekeeping
genes) can be implemented. Reads per million mapped reads
(RPM), reads per kilobase per million mapped reads (RPKM)
[92], median, and upper-quantile normalizations [93] rescale
the raw counts based on mean, mean with gene length consid-
ered, median, and upper-quantile of read counts, respectively,
in a sample. Full-quantile normalization [94] aligns all quan-
tiles of the count distributions among samples. Other than
direct comparison of the rescaled RNA abundance signal
across samples, dataset normalization also involves a variety
of analyses, including statistical modeling and hypothesis test-
ing that are used to delineate and compare the read-count-
based proﬁles of samples and datasets (Table 3). GC-content
[95], DESeq [96], trimmed mean of M values (TMM) [97],
remove unwanted variation (RUV) [98], Poisson beta [32],
and Sphinx [31] utilize statistical modeling to infer normalized
read counts. Owing to the distribution assumed, DESeq,
TMM, RUV, Poisson beta, and Sphinx allow over-
dispersion on read counts. In particular, Poisson beta and
Sphinx can identify transcriptional status through bimodality,
which characterizes the single-cell RNA-seq signal proﬁles.
Because of the regression method used, GC-content, DESeq,
TMM, and RUV can model batch effect and other known fac-
tors such as cycles of PCR ampliﬁcation and length distribu-
tion of fragments.
We hereby propose a workﬂow for inter-institutional
scRNA-seq data integration and analysis (Figure 3). The work-
ﬂow consists of four layers: Hadoop, normalization, analysis,
and veriﬁcation. (1) Hadoop layer. Inter-institutional
scRNA-seq data is stored and managed in this layer using
HDFS. Parallel algorithms, such as short-read alignment and
read count per transcript algorithms, can be implemented
under Hadoop framework provided in this layer. (2)
Table 2 Hadoop-based bioinformatics software tools
Function Name Weblink Description Ref.
Sequence ﬁle management LFQC http://engr.uconn.edu/rajasek/lfqc-v1.1.zip A lossless compression algorithm for FASTQ ﬁles [61]
Quake http://www.cbcb.umd.edu/software/quake Quality-guided error detection and correction of short reads [62]
SeqPig http://sourceforge.net/projects/seqpig/ Simple and scalable scripting for large sequencing datasets [63]
Hadoop-BAM http://sourceforge.net/projects/hadoop-bam/ Library for scalable manipulation of aligned NGS data [64]
smallWig http://publish.illinois.edu/milenkovic/ Parallel compression of RNA-seq WIG ﬁles [65]
Search engine SeqWare http://seqware.sourceforge.net Pipeline and query engine for storing and searching sequence [66]
Hydra http://code.google.com/p/hydra-proteomics/ A protein sequence database search engine [67]
SparkSeq https://bitbucket.org/mwiewiorka/sparkseq/ Interactive data querying of genomic data analysis [68]
GMQL http://www.bioinformatics.deib.polimi.it/GMQL/ Large-scale genomic data query and management [69]
Genomic sequence mapping CloudAligner http://mine.cs.wayne.edu:8080/CloudAligner/ A MapReduce-based application for short read alignment [70]
CouldBurst http://cloudburst-bio.sourceforge.net/ A parallel short read mapper [71]
BigBWA https://github.com/citiususc/BigBWA Hadoop implementation of BWA [72]
SEAL http://biodoop-seal.sourceforge.net/ Alignment, manipulation, and analysis of short reads [73]
DistMap http://code.google.com/p/distmap/ A toolkit for distributed short read mapping [74]
SOAP3 http://www.cs.hku.hk/2bwt-tools/soap3 Short sequence read alignment with GPU acceleration [75]
GPU-BLAST http://archimedes.cheme.cmu.edu/biosoftware.html NCBI-BLAST with GPU acceleration [76]
Expression analysis Myrna http://bowtie-bio.sf.net/myrna RNA sequencing diﬀerential expression analysis [77]
Eoulsan http://transcriptome.ens.fr/eoulsan/ Pipeline for calculating diﬀerential gene expression [78]
YunBe http://tinyurl.com/yunbedownload A gene set analysis algorithm for biomarker identiﬁcation [79]
FX http://fx.gmi.ac.kr Gene expression estimation and genomic variant calling [80]
Phylogenetic analysis FVGWAS http://www.nitrc.org/projects/fvgwas Fast voxel-wise genome-wide association analysis [81]
GATK http://www.broadinstitute.org/gsa/wiki/index.php/
The_Genome_Analysis_Toolkit
Variant calling [82]
Crossbow http://bowtie-bio.sourceforge.net/crossbow/ Alignment and SNP genotyping with Bowtie and SoapSNP [83]
MrsRF http://mrsrf.googlecode.com Calculate Robinson–Foulds distance between trees [84]
BlueSNP http://github.com/ibm-bioinformatics/bluesnp Genome-wide association studies using Hadoop clusters [85]
GeneCOST www.igbam.bilgem.tubitak.gov.tr/en/softwares/
genecost-en/index.html
Scoring-based prioritization to identify disease-causing genes [86]
Nephele http://code.google.com/p/nephele/ Genotyping via complete composition vector [87]
Miscellaneous PeakRanger http://www.modencode.org/software/ranger/ A cloud-enabled peak caller for ChIP-seq data [88]
SeqHBase http://seqhbase.omicspace.org A big-data toolset for family-based sequencing data analysis [89]
ProKinO http://vulcan.cs.uga.edu/prokino A uniﬁed resource for mining the cancer kinome [90]
BioPig https://sites.google.com/a/lbl.gov/biopig/ An analytic toolkit for large-scale sequence data [91]
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26 Genomics Proteomics Bioinformatics 14 (2016) 21–30Normalization layer. To make the single-cell expression pro-
ﬁles comparable across different studies or even across differ-
ent chips/runs for the same study, normalization is not just the
most important task but also the biggest challenge. Normaliza-
tion covers the analyses that are performed to control the
cross-assay technical variation. Nonetheless, different normal-
ization strategies should be extensively tested and compared.
As discussed, single-cell RNA-seq exhibits unique bimodal
transcriptional proﬁles that can be resolved into ‘‘on” and
‘‘off” components. This unique transcriptional pattern distin-
guishes the single-cell RNA-seq analyses from traditional
bulk-cell RNA-seq and provides a naturally normalized signal
proﬁle for comparison. (3) Analysis layer. In this layer, the
normalized single-cell gene expression proﬁles are loaded as
input. The output of the analysis is the target gene sets that
drive the divergence of the cellular phenotypes or
experimentally-controlled cellular groups. Determination of
differential expression and co-expression, as well as bicluster-
ing will be implemented in this layer to identify the pattern
in gene expression proﬁles. The target gene sets or the classiﬁ-
cation of the cell populations will be further interpreted in the
veriﬁcation layer. (4) Veriﬁcation layer. In this layer, the bio-
logical signiﬁcance of the input gene set will be analyzed, inter-
preted, and veriﬁed using tools such as the gene set enrichment
analysis (GSEA), and gene ontology (GO)-term enrichment
analysis, as well as the database for annotation, visualization
and integrated discovery (DAVID) functional analysis, etc.
Outlook
Big data and scRNAseq are two rapid-growing technologies.
Big data not only can provide the framework to host, process,
transform, and visualize the data from different sources, but
also can increase the sample power by including comprehen-
sive sample descriptions and ruling out cross-study batch
effects. Notably, the big-data framework offers the opportu-
nity to identify signiﬁcant correlation in new dimensionalities,
with the sample power that cannot be reached by individual
studies on these dimensionalities. One possible application of
big data for scRNA-seq is in mammalian single-cell studies,
which are often associated with the origin of cells from differ-
ent body parts. This means the assayed single cells can be
mapped spatially. The atlas of cell phenotypes or interactive
behaviors can be further explored in this way. This spatial data
infrastructure has been widely used in geoinformatics and has
now become a popular methodology of big data. For instance,
the Human Protein Atlas project is one of the research efforts
that is taking the idea to the protein level [99]. As the vehicles
of the DNA, RNA, and protein molecules, single cells carry
the molecular signature of the phenotypic and functional ele-
ments. They should also be able to be systematically assayed
and organized in the big-data domain.
Many diseases, especially cancer, are heterogeneous when
considered from two different perspectives. On the one hand,
cancer tissues are heterogeneous and thus require the high-
resolution information that can be obtained from single-cell
technology. On the other hand, certain cancer categories are
actually deﬁned from a heterogeneous patient population that
requires personalized solutions. Big-data technology has been
recognized by Doudican et al. for its ability to inform person-
alized therapeutics [100]. Irish and Doxie have recently
Figure 3 Workflow of inter-institutional scRNA-seq data integration
Inter-institutional single-cell RNA-seq datasets are aligned against their genomes at the Hadoop layer. Read counts are resolved into gene
‘‘on” or ‘‘off” status at the normalization layer. Differential expression, co-expression, and other applications are developed based on gene
‘‘on” or ‘‘off” status instead of gene expression. Biology in the resulting gene list is veriﬁed by GSEA, GO-term enrichment analysis,
DAVID functional analysis or other tools. GSEA, gene set enrichment analysis; GO, gene ontology; DAVID, database for annotation,
visualization and integrated discovery.
Yu P and Lin W / scRNA-seq and Big Data 27reviewed the progress of applying single-cell technology to can-
cer biology [101], and the advancements are signiﬁcant. The
big-data infrastructure of the ever-increasing number of
single-cell RNA-seq datasets will eventually facilitate the deci-
sions that are based on the comparison of clinical sample char-
acteristics at a higher resolution, as well as interrogation of
previous treatment responses within larger datasets.Competing interests
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